It is mainly used in research as one of the peptides for prostate health, particularly in treating advanced prostate cancer
Dogs in the placebo group showed a statistically significant decline over the same period
I mean, it seems like you've done a great job
Similarly, silymarin protected against ischemia-reperfusion injury, a pro-oxidative state and a major contributor to acute kidney injury, when given to rats at a dose equivalent to about 567 mg for an adult human (Senturk 2008)
Three further Phase 3 trial results in the TRIUMPH programme are due before the end of 2026: TRIUMPH-2 in obesity with type 2 diabetes, TRIUMPH-3 in obesity with established cardiovascular disease (with further safety information relevant to higher-risk populations), and obstructive sleep apnoea
And it's literally just me and my wife and our sons